A highly convergent and efficient synthesis of a macrocyclic hepatitis C virus protease inhibitor BI 201302

Org Lett. 2013 Mar 1;15(5):1016-9. doi: 10.1021/ol303498m. Epub 2013 Feb 13.

Abstract

A highly convergent large scale synthesis of a 15-membered macrocyclic hepatitis C virus (HCV) protease inhibitor BI 201302 was achieved, in which the key features are the practical macrocyclization by Ru-catalyzed ring-closing metathesis (0.1 mol % Grela catalyst, 0.1-0.2 M concentration) and the efficient sulfone-mediated SNAr reaction.

MeSH terms

  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Catalysis
  • Cyclization
  • Hepacivirus / drug effects*
  • Molecular Structure
  • Peptides, Cyclic / chemical synthesis*
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / pharmacology*
  • Protease Inhibitors / chemical synthesis*
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology*

Substances

  • Antiviral Agents
  • BI 201302
  • Peptides, Cyclic
  • Protease Inhibitors